Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.52B |
| 2 |
NVIDIA
NVDA
|
+$732M |
| 3 |
ProShares UltraPro QQQ
TQQQ
|
+$555M |
| 4 |
Dell
DELL
|
+$542M |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.18B |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.29B |
| 3 |
Visa
V
|
+$1.12B |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$918M |
| 5 |
Broadcom
AVGO
|
+$892M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.93% |
| 2 | Consumer Discretionary | 1.52% |
| 3 | Healthcare | 0.84% |
| 4 | Financials | 0.83% |
| 5 | Communication Services | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PR
8676
Permian Resources
PR
$17.7B
| $176K | ﹤0.01% |
12,904
-2,083,649
| -99% | -$30.6M |
|
|
DFTX
8677
Definium Therapeutics
DFTX
$5.81B
| $175K | ﹤0.01% |
30,721
-47,552
| -61% | -$331K |
|
8678
Richtech Robotics
RR
$371M
| $174K | ﹤0.01% |
+207,670
| New | +$226K |
|
8679
Algoma Steel Group Warrant
ASTLW
$99.1K
| $174K | ﹤0.01% |
100,726
+75
| +0.1% | +$108 |
|
8680
YieldMax NFLX Option Income Strategy ETF
NFLY
$38.4M
| $174K | ﹤0.01% |
+10,123
| New | +$170K |
|
|
VXRT
8681
DELISTED
Vaxart
VXRT
| $173K | ﹤0.01% |
+204,335
| New | +$156K |
|
|
SMCX
8682
Defiance Daily Target 2X Long SMCI ETF
SMCX
$200M
| $173K | ﹤0.01% |
+559
| New | +$225K |
|
8683
Nomura Holdings
NMR
$28.6B
| $173K | ﹤0.01% |
33,143
+19,763
| +148% | +$112K |
|
8684
Foghorn Therapeutics
FHTX
$358M
| $173K | ﹤0.01% |
18,547
-15,580
| -46% | -$113K |
|
|
FFC
8685
Flaherty & Crumrine Preferred and Income Securities Fund
FFC
$783M
| $173K | ﹤0.01% |
+10,520
| New | +$162K |
|
8686
CALL
Black Diamond Therapeutics
BDTX
$114M
| $172K | ﹤0.01% |
+39,500
| New | +$215K |
|
8687
CALL
Cushman & Wakefield Ltd
CWK
$3.12B
| $172K | ﹤0.01% |
12,600
-600
| -5% | -$7.57K |
|
8688
Invesco DB Oil Fund
DBO
$389M
| $171K | ﹤0.01% |
12,272
-381,613
| -97% | -$5.68M |
|
|
DSL
8689
DoubleLine Income Solutions Fund
DSL
$1.23B
| $171K | ﹤0.01% |
+13,194
| New | +$169K |
|
|
GENT
8690
Genter Capital Taxable Quality Intermediate ETF
GENT
$102M
| $171K | ﹤0.01% |
16,414
-2,496
| -13% | -$25.8K |
|
8691
Kingstone Companies
KINS
$272M
| $170K | ﹤0.01% |
+18,581
| New | +$144K |
|
8692
Karyopharm Therapeutics
KPTI
$44.6M
| $170K | ﹤0.01% |
13,650
-89,682
| -87% | -$1.11M |
|
8693
BlackRock Debt Strategies Fund
DSU
$597M
| $170K | ﹤0.01% |
+15,401
| New | +$168K |
|
8694
PUT
Crescent Energy
CRGY
$4.05B
| $170K | ﹤0.01% |
15,500
-61,800
| -80% | -$706K |
|
8695
iShares MSCI UAE ETF
UAE
$319M
| $169K | ﹤0.01% |
11,103
-93,036
| -89% | -$1.36M |
|
8696
NET Power
NPWR
$138M
| $168K | ﹤0.01% |
24,029
-15,160
| -39% | -$127K |
|
8697
Roivant Sciences
ROIV
$25.8B
| $168K | ﹤0.01% |
14,596
-2,493,187
| -99% | -$28.4M |
|
8698
CVRx
CVRX
$60.8M
| $168K | ﹤0.01% |
19,038
+5,053
| +36% | +$45.9K |
|
8699
ADC Therapeutics
ADCT
$144M
| $167K | ﹤0.01% |
53,126
+38,859
| +272% | +$123K |
|
|
YSG
8700
Yatsen Holding
YSG
$314M
| $167K | ﹤0.01% |
49,019
-91,267
| -65% | -$315K |
|
Similar funds
Jane Street's Q3 2024 Portfolio in Review
As of Q3 2024, Jane Street held 10,828 positions worth $453B, up 3.6% from $438B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Jane Street withdrew a net $18.5B in Q3 2024, closing 1,349 positions and reducing 4,327 holdings. Its most notable exit was iShares Core MSCI International Developed Markets ETF, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 2.9% of assets, down from 4.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jane Street opened a new position in Schwab Short-Term US Treasury ETF worth $424M.
- Jane Street's largest Q3 2024 buy was Schwab Short-Term US Treasury ETF: 17,304,274 shares worth $424M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.52B increase.
- Jane Street's biggest Q3 2024 reduction was Apple, cutting an estimated $4.18B.
- Jane Street fully exited iShares Core MSCI International Developed Markets ETF in Q3 2024, selling an estimated $290M.
- Jane Street's ten largest holdings make up 44% of its $453B portfolio in Q3 2024.
- Jane Street opened 1,593 new positions and closed 1,349 in Q3 2024.
- Jane Street's portfolio value rose 3.6% quarter-over-quarter to $453B.
Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.